Press release
Leading Growth Driver in the Ischemic Heart Disease (IHD) Drugs Market in 2025: Rising Prevalence Of Obesity And Diabetes Fuels Expansion Of The Ischemic Heart Disease (IHD) Drugs Market Driver's Influence
Leading Growth Driver in the Ischemic Heart Disease
The ischemic heart disease (IHD) drugs market will grow from $6.36 billion in 2024 to $6.71 billion in 2025, at a CAGR of 5.6%. Growth drivers include the rising global prevalence of ischemic heart disease, increased awareness and diagnostics, changes in lifestyle and dietary patterns, government cardiovascular health initiatives, and clinical trial collaborations.
The Ischemic Heart Disease (IHD) Drugs market will reach $7.86 billion by 2029 at a CAGR of 4.0%, driven by aging population trends, personalized medicine, and cardiovascular prevention. Trends include precision medicine, novel anti-atherogenic agents, lipid-lowering therapies, and anti-inflammatory agent integration.
What Is Contributing to the Growth of the Ischemic Heart Disease (IHD) Drugs Market?
The rising prevalence of obesity and diabetes is expected to propel the growth of the ischemic heart disease (IHD) drugs market. Diabetes is a long-term metabolic condition characterized by high blood glucose levels, while obesity involves excessive body fat accumulation that negatively impacts health. IHD drugs help manage cardiovascular risks, such as hypertension and dyslipidemia, in individuals with obesity and diabetes, reducing the risk of ischemic heart disease. For example, the World Obesity Federation projected that by 2030, one billion people globally will suffer from obesity. Furthermore, in June 2024, the NHS reported a significant increase in people at risk of developing type 2 diabetes, with the number growing by nearly 20% from 2022 to 2023. The rising prevalence of obesity and diabetes is thus driving the demand for IHD drugs.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13467&type=smp
Which Key Market Leaders Are Driving Ischemic Heart Disease (IHD) Drugs Industry Growth?
Major companies operating in the ischemic heart disease (ihd) drugs market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sandoz Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Lupin Limited, Recordati S.p.A., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alembic Pharmaceuticals Ltd., Eagle Pharmaceuticals Inc., Accord Healthcare Limited, Macleods Pharmaceuticals Ltd., WG Critical Care LLC, Novitium Pharma LLC
What Are the Emerging Trends in the Ischemic Heart Disease (IHD) Drugs Industry?
Finally, leading firms in the ischemic heart disease (IHD) drugs market are innovating new treatments such as Camzyos, the first cardiac myosin inhibitor for hypertrophic cardiomyopathy (HCM). In April 2022, Bristol Myers Squibb introduced Camzyos (mavacamten), reducing hypercontractility and improving heart function in HCM patients.
What Are the Main Segments in the Ischemic Heart Disease (IHD) Drugs Market?
The ischemic heart disease (IHD) drugs market covered in this report is segmented -
1) By Drug Class: Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, Angiotensin-converting enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Vasodilators, Antithrombotic Agents
2) By Disease Class: Angina Pectoris, Myocardial Infarction
3) By End User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Anti-Dyslipidemic Drugs: Statins, Fibrates, Niacin, Cholesterol Absorption Inhibitors
2) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
3) By Beta-Blockers: Cardioselective Beta-Blockers, Non-Selective Beta-Blockers, Vasodilating Beta-Blockers
4) By Angiotensin-Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril
5) By Angiotensin II Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan
6) By Vasodilators: Nitroglycerin, Isosorbide Dinitrate, Hydralazine
7) By Antithrombotic Agents: Antiplatelet Drugs, Anticoagulants
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ischemic-heart-disease-ihd-drugs-global-market-report
Which Geographic Area Leads the Ischemic Heart Disease (IHD) Drugs Market?
North America was the largest region in the ischemic heart disease (IHD) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ischemic heart disease (ihd) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Ischemic Heart Disease (IHD) Drugs Global Market Report?
- Market Size Analysis: Analyze the Ischemic Heart Disease (IHD) Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Ischemic Heart Disease (IHD) Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Ischemic Heart Disease (IHD) Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Ischemic Heart Disease (IHD) Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Ischemic Heart Disease (IHD) Drugs Market in 2025: Rising Prevalence Of Obesity And Diabetes Fuels Expansion Of The Ischemic Heart Disease (IHD) Drugs Market Driver's Influence here
News-ID: 3851466 • Views: …
More Releases from The Business research company
Outlook for the Ready To Drink (RTD) Alcoholic Beverages Market: Major Segments, …
The ready-to-drink (RTD) alcoholic beverages market is on track to experience significant growth over the coming years, driven by evolving consumer preferences and industry innovations. This sector is rapidly expanding as more consumers seek premium, convenient, and sustainable options in their alcoholic beverage choices. Let's explore the market's projected size, key drivers, major players, emerging trends, and segmentation details shaping its future.
Projected Expansion and Market Size of the Ready To…
Emerging Sub-Segments Transforming the Pumpkin Seed Protein Market Landscape
The pumpkin seed protein market is emerging as a promising sector within the broader landscape of plant-based proteins. With increasing consumer interest in alternative, allergen-free protein sources and sustainable nutrition, this market is set to witness substantial growth and innovation. Let's explore the market size projections, key players, current trends, and major product segments shaping the future of pumpkin seed protein.
Projected Market Valuation and Growth Expectations for Pumpkin Seed Protein…
Top Players and Market Competition in the Protein Hydrolysates Industry
The protein hydrolysates market is positioned for significant expansion in the coming years as consumer preferences and nutritional science continue to evolve. With increasing attention on tailored nutrition solutions and the rise of plant-based options, this market is gearing up for robust growth and innovation.
Protein Hydrolysates Market Size Projections Through 2030
The protein hydrolysates market is forecasted to grow substantially, reaching a value of $7.25 billion by 2030. This…
Processed Meat Market Overview: Major Segments, Strategic Developments, and Lead …
The processed meat industry is positioned for substantial expansion over the coming years, driven by evolving consumer preferences and technological advancements. As the market adapts to changing demands and regulatory landscapes, it is expected to reach impressive valuation milestones. Let's explore the current market size, key players, emerging trends, and detailed segment analyses shaping this sector's future.
Forecasted Market Size and Growth Trajectory of the Processed Meat Market
The processed…
More Releases for IHD
Rising Prevalence Of Obesity And Diabetes Fuels Expansion Of The Ischemic Heart …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Ischemic Heart Disease (IHD) Drugs Market Through 2025?
The market for ischemic heart disease (IHD) medications has seen substantial growth in the past few years. The market is predicted to expand from $6.36 billion in 2024 to $6.71 billion in 2025, showcasing…
Rising Prevalence Of Obesity And Diabetes Fuels Expansion Of The Ischemic Heart …
The Ischemic Heart Disease (IHD) Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Ischemic Heart Disease (IHD) Drugs Market Size and Projected Growth Rate?
The market size for drugs treating ischemic heart disease (IHD) has experienced robust growth in recent years. It…
Ischemic Heart Disease (IHD) Drugs Market Outlook 2024-2033 - Market Research An …
"The Business Research Company recently released a comprehensive report on the Global Ischemic Heart Disease (IHD) Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the…
Ischemic Heart Disease (IHD) Drugs Market Growth, Size, Key Drivers, Forecast To …
The ischemic heart disease (ihd) drugs market size has grown strongly in recent years. It will grow from $6.02 billion in 2023 to $6.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising global prevalence of ischemic heart disease, increased awareness and diagnostics, changes in lifestyle and dietary patterns, government initiatives for cardiovascular health, collaborations…
Ischemic Heart Disease IHD Drugs Market Report 2024-2033 | Size, Share Analysis …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Ischemic Heart Disease IHD Drugs Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The ischemic heart disease (ihd) drugs market size has…
Ischemic Heart Disease (IHD)Drugs Market Healthcare Equipment, Highlights, Exper …
The report titled “Ischemic Heart Disease (IHD)Drugs Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts.
The Ischemic Heart Disease (IHD)Drugs…
